Dr W. Keith Tan

Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

University departments
Department of Oncology
MRC Cancer Unit
Hutchison MRC Research Centre
University institutes
Hutchison MRC Research Centre
CRUK Cambridge Institute

Position: PhD student
Personal home page: https://www.linkedin.com/in/w-keith-tan-013079126/?trk=public_profile_browsemap&originalSubdomain=uk
Email:   weikeithtan@gmail.com

PubMed journal articles - click here

Research Programme
Early Cancer Institute
Methods and technologies
Clinical practice
Clinical trials
Tumour type interests

Key publications

How to Succeed in the Academic Clinical interview. Wei Keith Tan, Rory J. Piper. Cambridge University Press November 2020. Available at: https://www.amazon.co.uk/How-Succeed-Academic-Clinical-Interview/dp/1108...

1) One vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention. Tan WK.JAMA. 2019 Nov 5;322(17):1715. doi: 10.1001/jama.2019.14223.

2) Random biopsy of the neosquamous epithelium is a waste of time and money. Tan WK, Shaheen NJ.Gastrointest Endosc. 2019 Sep;90(3):404-406. doi: 10.1016/j.gie.2019.05.008.

3) Progress in Screening for Barrett's Esophagus: Beyond Standard Upper Endoscopy. Tan WK, Sharma AN, Chak A, Fitzgerald RC. Gastrointest Endosc Clin N Am. 2021 Jan;31(1):43-58. doi: 10.1016/j.giec.2020.08.004.

4) Standard versus simplified radiofrequency ablation protocol for Barrett's esophagus: comparative analysis of the whole treatment pathway. Tan WK, Ragunath K, White JR, Santiago J, Fernandez-Sordo JO, Pana M, Alias B, Hadjinicolaou AV, Sujendran V, di Pietro M. Endosc Int Open. 2020 Feb;8(2):E189-E195. doi: 10.1055/a-1005-6331. Epub 2020 Jan 22.

5) Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study. Sami SS, Ravindran A, Kahn A, Snyder D, Santiago J, Ortiz-Fernandez-Sordo J, Tan WK, Dierkhising RA, Crook JE, Heckman MG, Johnson ML, Lansing R, Ragunath K, di Pietro M, Wolfsen H, Ramirez F, Fleischer D, Wang KK, Leggett CL, Katzka DA, Iyer PG.Gut. 2019 Aug;68(8):1379-1385. doi: 10.1136/gutjnl-2018-317513. Epub 2019 Jan 11.

6) Single-bite versus double-bite technique for mapping biopsies during endoscopic surveillance for hereditary diffuse gastric cancer: a single-center, randomized trial. *Pappas A, *Tan WK, Waldock W, Richardson S, Tripathi M, Januszewicz W, Roberts G, O'Donovan M, Fitzgerald RC, di Pietro M. Endoscopy. 2021 Mar;53(3):246-253. doi: 10.1055/a-1201-3125. Epub 2020 Jul 17. *Denotes joint first author

7) Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients. *Januszewicz W, *Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators.Clin Gastroenterol Hepatol. 2019 Mar;17(4):647-656.e1. doi: 10.1016/j.cgh.2018.07.043. Epub 2018 Aug 9. *Denotes joint first author

8) Comparative outcomes of radiofrequency ablation for Barrett's oesophagus with different baseline histology. Tan WK, Rattan A, O'Donovan M, Nuckcheddy T, Alias B, Sujendran V, di Pietro M.United European Gastroenterol J. 2018 Jun;6(5):662-668. doi: 10.1177/2050640617752183. Epub 2018 Jan 17.

9) Pastpresent and future of Barrett's oesophagus. Tan WK, di Pietro M, Fitzgerald RC.Eur J Surg Oncol. 2017 Jul;43(7):1148-1160. doi: 10.1016/j.ejso.2017.02.004. Epub 2017 Feb 16.

10) A crosssectional analysis of Facebook comments to study public perception of a new diagnostic test called the Cytosponge. Tan WK, Muldrew B, Khan Z, Fitzgerald RC.Dis Esophagus. 2019 Jan 1;32(1):10.1093/dote/doy085. doi: 10.1093/dote/doy085.